Yüklüyor......
Is immune checkpoint inhibitor-associated diabetes the same as fulminant type 1 diabetes mellitus?
Pembrolizumab is an anti-cancer drug that targets programmed cell death protein-1 (PD-1) receptors on lymphocytes resulting in their activation against tumour cells. PD-1 receptors are also interspersed in endocrine organs and pembrolizumab use has long been associated with hypophysitis and thyroidi...
Kaydedildi:
| Yayımlandı: | Clin Med (Lond) |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Royal College of Physicians
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7385772/ https://ncbi.nlm.nih.gov/pubmed/32675150 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7861/clinmed.2020-0054 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|